ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Results available

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease

ClinicalTrials.gov ID: NCT02726386

Public ClinicalTrials.gov record NCT02726386. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 9:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, International, Open-label, Safety Study of ND0612, a Solution of Levodopa/Carbidopa Delivered Via a Pump System as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease

Study identification

NCT ID
NCT02726386
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
NeuroDerm Ltd.
Industry
Enrollment
214 participants

Conditions and interventions

Interventions

  • ND0612 Drug

Drug

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 3, 2016
Primary completion
Sep 8, 2019
Completion
Jan 31, 2027
Last update posted
May 29, 2025

2016 – 2027

United States locations

U.S. sites
26
U.S. states
14
U.S. cities
26
Facility City State ZIP Site status
Xenoscience Phoenix Arizona 85004
Clinical Trials Inc. Little Rock Arkansas 72205-6421
The Parkinsons and Movement Disorder Institute Fountain Valley California 92708-5153
Neuro Pain Medical Center Fresno California 93710
University of Colorado Denver Aurora Colorado 80045
Rocky Mountain Movement Disorders Center Englewood Colorado 80113-2776
Parkinson's Disease and Movement Disorder Center of Boca Raton Boca Raton Florida 33486-2359
MD Clinical Hallandale Florida 33009
Infinity Clinical Research, LLC Hollywood Florida 33021
University of Florida Health at Jacksonville Jacksonville Florida 32209
Neurology Associates, PA Maitland Florida 32751-4723
Parkinsons Disease Treatment Center of Southwest Florida Port Charlotte Florida 33980
Suncoast Neuroscience Associates St. Petersburg Florida 33713-8844
Infinity Clinical Research, LLC Sunrise Florida 33351
USF Health Parkinson's Disease and Movement Disorders Tampa Florida 33613
Northwestern University Chicago Illinois 60611
Unity Point Health Des Moines Iowa 50309
University of Maryland, Neurology Baltimore Maryland 21201
QUEST Research Institute Farmington Hills Michigan 48334
Henry Ford Hospital West Bloomfield Michigan 48322-3013
Pyramid Clinical Research Somerset New Jersey 08873-3448
University of Cincinnati Cincinnati Ohio 45267
The Movement Disorder Clinic of Oklahoma Tulsa Oklahoma 74136
Synergy Trials Richmond Virginia 23226
Sentara Neuroscience Institute Virginia Beach Virginia 23456-0168
Premier Research Spokane Washington 99202-1461

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02726386, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02726386 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →